CC
BSX icon

ClearArc Capital’s Boston Scientific BSX Stock Holding History

ClearArc Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$673K Sell
14,873
-6,097
-29% -$255K 0.26% 97
2019
Q3 		$853K Buy
20,970
+227
+1% +$9.62K 0.25% 98
2019
Q2 		$892K Sell
20,743
-2,456
-11% -$94.5K 0.26% 91
2019
Q1 		$890K Sell
23,199
-548
-2% -$20.9K 0.24% 99
2018
Q4 		$839K Sell
23,747
-12,000
-34% -$435K 0.25% 98
2018
Q3 		$1.38M Buy
35,747
+424
+1% +$14.8K 0.18% 126
2018
Q2 		$1.16M Buy
35,323
+229
+0.7% +$6.91K 0.16% 140
2018
Q1 		$959K Buy
35,094
+115
+0.3% +$3.13K 0.14% 162
2017
Q4 		$867K Sell
34,979
-293
-0.8% -$8.08K 0.12% 181
2017
Q3 		$1.03M Buy
35,272
+1,696
+5% +$46.8K 0.15% 143
2017
Q2 		$931K Buy
33,576
+254
+0.8% +$6.74K 0.15% 153
2017
Q1 		$829K Buy
33,322
+251
+0.8% +$6.1K 0.14% 160
2016
Q4 		$715K Sell
33,071
-261
-0.8% -$5.7K 0.13% 175
2016
Q3 		$793K Buy
33,332
+353
+1% +$8.42K 0.15% 159
2016
Q2 		$771K Buy
32,979
+114
+0.3% +$2.47K 0.15% 156
2016
Q1 		$618K Sell
32,865
-38
-0.1% -$668 0.13% 183
2015
Q4 		$607K Buy
32,903
+289
+0.9% +$5.18K 0.13% 201
2015
Q3 		$535K Sell
32,614
-572
-2% -$9.78K 0.11% 228
2015
Q2 		$587K Buy
33,186
+4,358
+15% +$77.9K 0.11% 225
2015
Q1 		$512K Buy
28,828
+556
+2% +$8.79K 0.11% 229
2014
Q4 		$375K Buy
28,272
+887
+3% +$11.3K 0.08% 286
2014
Q3 		$323K Buy
27,385
+785
+3% +$9.88K 0.07% 288
2014
Q2 		$340K Buy
26,600
+378
+1% +$4.92K 0.08% 275
2014
Q1 		$355K Buy
26,222
+1,347
+5% +$17.7K 0.09% 263
2013
Q4 		$299K Sell
24,875
-1,322
-5% -$15.6K 0.08% 285
2013
Q3 		$308K Buy
26,197
+267
+1% +$2.89K 0.09% 260
2013
Q2 		$240K Buy
+25,930
New +$220K 0.06% 320

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

ClearArc Capital's BSX Position: Q4 2019 in Review

ClearArc Capital reduced its Boston Scientific (BSX) stake by 29% in Q4 2019, selling an estimated $255K and leaving 14,873 shares worth $673K. The position accounts for 0.26% of the portfolio, ranked #97.

ClearArc Capital first reported a position in BSX in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.38M in Q3 2018. 854 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

  • ClearArc Capital held 14,873 shares of Boston Scientific worth $673K as of Q4 2019.
  • ClearArc Capital sold 6,097 Boston Scientific shares in Q4 2019, an estimated $255K.
  • Boston Scientific made up 0.26% of ClearArc Capital's portfolio in Q4 2019, its #97 holding.
  • ClearArc Capital first reported a position in Boston Scientific in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Boston Scientific position peaked at $1.38M in Q3 2018.
  • 854 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.